Today’s talk is brought to you by the book Direxion:
Michael and I had Dave Mazza, managing director and head of product, to talk about the Direxion ETF and their new mRNA-focused ETF.
In today’s show we discuss:
- Why the mRNA ETF was needed
- How mRNA was misunderstood
- Threshold to enter mRNA ETFs
- How This Thematic ETF Can Be Used
- How to Think About Investing in Biotech
- Current events affecting the biotech space
- mRNA as a technology, stimulus and treatment for diseases
Follow us on Facebook, Instagram and YouTube.
See our T-shirts, stickers, coffee mugs and other swags here.